Skip to content

   Pharma Publications

Neuropsychopharmacology
  • In Memoriam: Larry J. Young, PhD
    Published on 2024-06-15
    2 years ago
  • Extinction training suppresses activity of fear memory ensembles across the hippocampus and alters transcriptomes of fear-encoding cells
    Published on 2024-06-14
    2 years ago
  • Genome-wide association studies of coffee intake in UK/US participants of European ancestry uncover cohort-specific genetic associations
    Published on 2024-06-11
    2 years ago
  • Cracking the chicken and egg problem of schizophrenia and substance use: Genetic interplay between schizophrenia, cannabis use disorder, and tobacco smoking
    Published on 2024-06-11
    2 years ago
  • Smoking-informed methylation and expression QTLs in human brain and colocalization with smoking-associated genetic loci
    Published on 2024-06-04
    2 years ago
  • Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolam
    Published on 2024-05-31
    2 years ago
  • Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks
    Published on 2024-05-28
    2 years ago
« Previous 1 … 78 79 80 81 82 … 143 Next »
Journal of Psychopharmacology
  • The cortical silent period in schizophrenia: A systematic review and meta-analysis focusing on disease stage and antipsychotic medication
    Published on 2022-04-27
    4 years ago
  • Catechol-O-methyltransferase activity does not influence emotional processing in men
    Published on 2022-04-21
    4 years ago
  • To BDZ or not to BDZ? That is the question! Is there reliable scientific evidence for or against using benzodiazepines in the aftermath of potentially traumatic events for the prevention of PTSD? A systematic review and meta-analysis
    Published on 2022-04-19
    4 years ago
  • Do antipsychotic drugs shrink the brain? Probably not
    Published on 2022-04-09
    4 years ago
  • The effect of first- and second-generation antipsychotics on brain morphology in schizophrenia: A systematic review of longitudinal magnetic resonance studies with a randomized allocation to treatment arms
    Published on 2022-04-09
    4 years ago
  • Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms
    Published on 2022-04-07
    4 years ago
  • Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension
    Published on 2022-04-07
    4 years ago
« Previous 1 … 78 79 80 81 82 … 145 Next »
European Neuropsychopharmacology
  • Engineered extracellular vesicles and their promising therapeutic potential in neuropsychiatric disorders
    Published on 2022-07-30
    4 years ago
  • Polygenic risk scores for antisocial behavior in relation to amygdala morphology across an attention deficit hyperactivity disorder case-control sample with and without disruptive behavior
    Published on 2022-07-30
    4 years ago
  • Letter to the editor about the article “Engineered extracellular vesicles and their promising therapeutic potential in neuropsychiatric disorders” (Schulze TG et al., 2022)
    Published on 2022-07-29
    4 years ago
  • Early intervention and staging bipolar disorder: Conceptual and clinical dilemmas
    Published on 2022-07-27
    4 years ago
  • Non-prescribed use of gabapentinoids: Mechanisms, predisposing factors, associated hazards and clinical management
    Published on 2022-07-27
    4 years ago
  • Erratum to “Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the Art. [European Neuropsychopharmacology 60 (2022) 100–116]”
    Published on 2022-07-24
    4 years ago
  • Comment to “Requiem or resurrection: Classic monoamine oxidase inhibitors revisited”
    Published on 2022-07-24
    4 years ago
« Previous 1 … 78 79 80 81 82 … 166 Next »

   Pharma Pub